GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaxis Pharmaceutical Corp (OTCPK:CURXQ) » Definitions » Goodwill

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Goodwill : $0.00 Mil (As of Dec. 2011)


View and export this data going back to . Start your Free Trial

What is Curaxis Pharmaceutical Goodwill?

A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Curaxis Pharmaceutical's goodwill for the quarter that ended in Dec. 2011 was $0.00 Mil.


Curaxis Pharmaceutical Goodwill Historical Data

The historical data trend for Curaxis Pharmaceutical's Goodwill can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaxis Pharmaceutical Goodwill Chart

Curaxis Pharmaceutical Annual Data
Trend Dec08 Dec09 Dec10 Dec11
Goodwill
- - - -

Curaxis Pharmaceutical Semi-Annual Data
Dec08 Dec09 Dec10 Dec11
Goodwill - - - -

Curaxis Pharmaceutical Goodwill Calculation

A Goodwill is an intangible asset that arises as a result of the acquisition of one company by another for a premium value. The value of a company's brand name, solid customer base, good customer relations, good employee relations and any patents or proprietary technology represent goodwill. Goodwill is considered an intangible asset because it is not a physical asset like buildings or equipment. The goodwill account can be found in the assets portion of a company's balance sheet.


Curaxis Pharmaceutical  (OTCPK:CURXQ) Goodwill Explanation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Curaxis Pharmaceutical's Goodwill-to-Asset Ratio for the fiscal year that ended in Dec. 2011 is calculated as

Goodwill-to-Asset (A: Dec. 2011 )=Goodwill/Total Assets
=0/0.658
=

Curaxis Pharmaceutical's Goodwill-to-Asset Ratio for the quarter that ended in Dec. 2011 is calculated as

Goodwill-to-Asset (Q: Dec. 2011 )=Goodwill/Total Assets
=0/0.658
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


Curaxis Pharmaceutical Goodwill Related Terms

Thank you for viewing the detailed overview of Curaxis Pharmaceutical's Goodwill provided by GuruFocus.com. Please click on the following links to see related term pages.


Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.
Executives
Timothy R Wright director, officer: Chief Executive Officer C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Michael W George director C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Headlines

No Headlines